Global longitudinal strain as a predictor of outcomes in chronic Chagas´ cardiomyopathy
Minna Moreira Dias Romano1, Henrique Turin Moreira1, Fawaz Alenezi2
1Cardiology Center of the Medical School of Ribeirao Preto, University of São Paulo (USP), São Paulo, Brazil.
Insights
Global longitudinal strain (GLS) predicts cardiovascular events in Chronic Chagas cardiomyopathy (CCC). This finding offers a new tool for risk stratification in Chagas disease patients, independent of ejection fraction.
Area of Science:
- Cardiology
- Echocardiography
- Medical Diagnostics
Background:
- Chronic Chagas cardiomyopathy (CCC) significantly increases cardiovascular event risk.
- Global longitudinal strain (GLS) shows prognostic value in various cardiomyopathies.
- The predictive capability of GLS in CCC requires further investigation.
Purpose of the Study:
- To evaluate the prognostic significance of GLS in patients with CCC.
- To determine if GLS can predict adverse cardiovascular outcomes in CCC.
- To assess the utility of GLS for risk stratification in Chagas disease.
Main Methods:
- Retrospective echocardiography analysis with prospective follow-up.
- GLS measured using vendor-independent software from LV apical peak longitudinal strain.
- GLS categorized into tertiles for prognostic comparison.
Main Results:
- GLS was assessed in 77 CCC patients (mean age 56 ± 15 years).
- After 35 ± 19 months, 33 patients experienced composite adverse outcomes.
- Higher GLS values (≥ -13.8%) were significantly associated with worse prognosis (log rank p=0.001).
- Multivariate analysis confirmed GLS as an independent predictor of outcomes (HR 1.20, p=0.008), adjusted for age, gender, and LVEF.
Conclusions:
- Left ventricle GLS independently predicts cardiovascular outcomes in CCC patients.
- GLS serves as a valuable tool for risk stratification in Chagas disease, irrespective of LVEF.
Introduction:
Chronic Chagas cardiomyopathy (CCC) is associated with a high incidence of cardiovascular events. Global longitudinal strain (GLS) is useful in predicting adverse cardiovascular outcomes in several cardiomyopathies. However, its prognostic value in CCC is not well established.
Methods:
This study was a retrospective echocardiography analysis with prospective follow-up of CCC subjects. GLS was defined as the average of three apical peak longitudinal strain measurements of the LV using vendor-independent software. GLS groups were defined according to tertiles: (1) GLS ≤ -18.4%, (2) GLS > -18.4% and <-13.8%, and (3) GLS ≥ -13.8%. The primary outcome was a composite of death, hospitalization, sustained ventricular tachycardia (SVT), new heart failure, any systemic embolism, hospitalization, reverted cardiac arrest and cardiac heart transplantation.
Results:
GLS was obtained in 77 subjects, 50.6% were males and the mean age was 56 ± 15 years. There were 6.49% losses of follow-up and the mean LVEF was 51 ± 14%. After a follow-up period of 35 ± 19 months (2.9 y), 33 subjects reached the composite outcome. Death and hospitalization were the most frequent outcomes (n = 9), followed by new heart failure (n = 6), embolism (n = 6), and SVT (n = 3). The GLS ≥ -13.8% was associated with a worse prognosis when compared with the other tertile GLS groups (log rank-p-value = 0.001 for both comparisons). On the multivariate Cox proportional hazard model, adjusting for age, gender, and LVEF, GLS was an independent predictor of outcomes with an HR of 1.20 (CI = 1.05-1.38;p = 0.008).
Conclusion:
Left ventricle GLS is an independent predictor of cardiovascular outcomes in patients with CCC. GLS may be an important tool for Chagas disease risk stratification, independent of LVEF.
More Related Videos
07:21Magnetic Resonance Derived Myocardial Strain Assessment Using Feature Tracking
Published on: February 12, 2011
11:50High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart
Published on: July 9, 2010
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy I: Introduction and Classification
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
